Physician profile
Eric C Trautmann
NPI 1477599835
$2,330.98
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,819 · 2020: $255 · 2021: $243 · 2022: $13.91.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $282.05 | 2019-2021 | |
| Lilly USA, LLC | $274.32 | 2019-2022 | |
| Novo Nordisk INC | $236.50 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $229.55 | 2019-2021 | |
| Pfizer INC. | $225.48 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $223.76 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $131.53 | 2019-2021 | |
| Amgen INC. | $118.67 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $103.88 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.08 | 2019-2020 | |
| Allergan, INC. | $65.65 | 2019 | |
| Supernus Pharmaceuticals, INC. | $54.81 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $45.66 | 2019 | |
| Astellas Pharma US INC | $42.95 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $29.51 | 2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $27.22 | 2019 | |
| Mylan Specialty L.P. | $26.45 | 2019 | |
| Abbvie INC. | $23.09 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $22.11 | 2019 | |
| Sanofi Pasteur INC. | $20.28 | 2019 | |
| Sunovion Pharmaceuticals INC. | $17.00 | 2019 | |
| Shire North American Group INC | $16.35 | 2019 | |
| Abbott Laboratories | $16.18 | 2020 | |
| Ascensia Diabetes Care US INC. | $13.90 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Trautmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.